Gyroscope Therapeutics announced today that it launched the roadshow for its initial public offering of nearly 7 million shares. London-based Gyroscope’s U.S. offering includes up to 6.75 million American Depository Shares (ADSs) representing 6.75 million ordinary shares, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
Funding Roundup
Valeo Pharma closes upsized $6.6M private placement
Valeo Pharma announced today that it closed an upsized private placement worth more than $6.6 million. Montreal, Canada-based Valeo issued 6,645 unsecured, non-convertible debenture units at a purchase price of $1,000 per unit, totaling gross proceeds of $6.645 million, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
Glytec raises $21M for insulin dosing management tech
Glytec announced today that it raised $21 million in financing to fund its glycemic management technology. Waltham, Mass.-based Glytec received $9 million in debt financing from Silicon Valley Bank, combined with $12 million in equity funding, led by Savitr with contribution from other private investors, according to a news release. Get the full story at our […]
MedTech 100 roundup: New heights reached again
One week after recording its all-time best performance, the medtech industry again topped itself, storming even further ahead. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — has been on the rise since April began, with last week’s mark of 112.25 (April 16) representing an all-time best, topping the […]
Proximie raises $38M in Series B round
Digital surgery company Proximie this week announced it has raised $38 million in a Series B equity financing round. F-Prime Capital led the round, with participation from new investors Questa Capital, Eight Roads, Maverick Ventures. There was also support from existing investors Global Ventures, BECO Capital and Cedar Mundi Ventures. Proximie’s platform uses augmented reality (AR), machine […]
Endeavour Vision closes $375M financing for medtech growth fund
Endeavour Vision announced today that it closed the Endeavour Medtech Growth II fund at $375 million in capital commitments. Geneva, Switzerland-based Endeavour said in a news release that the fund is set up to support growth-stage medtech and digital health innovations. New and returning investors are supporting EMG II. The fund follows its original growth […]
NeuroPace shares take off on first day of trading
Epilepsy treatment developer NeuroPace (NSDQ:NPCE) shares skyrocketed today during its first day of trading on the Nasdaq market. Mountain View, Calif.-based NeuroPace shares were trading up 37.4% at $23.35 per share in mid-afternoon trading today. The company announced last month that it filed with the SEC to raise up to $75 million in an initial […]
Tesseract Health raises $80M Series B
Tesseract Health announced today that it raised $80 million in an oversubscribed Series B financing round. Guilford, Conn.–based Tesseract plans to use the funding to advance the development of its Tesseract iC eye imaging diagnostic technology platform by conducting research, accelerating the regulatory processes and ramping up manufacturing, according to a news release. Other potential […]
Virta Health raises $133M Series E for diabetes reversal tech
Virta Health announced today that it raised $133 million in a Series E equity financing round led by Tiger Global. San Francisco-based Virta said in a news release that the funds will accelerate its efforts to drive the adoption of its telehealth-based diabetes reversal treatment that aims to reverse the chronic disease while removing the need […]
MedTech 100 roundup: Industry skies to all-time high
The medtech industry hit a slight lull in the early stages of 2021 and, after signs of a rebound, it has soared beyond levels ever before seen. MassDevice‘s MedTech 100 Index had been building up steam in the month of April, rising from 102.16 points at the beginning of March all the way to 109.39 to […]
SeaSpine prices $87.8M offering
SeaSpine (NSDQ:SPNE) announced that it priced an underwritten public offering worth proceeds of approximately $87.8 million. Carlsbad, Calif.-based SeaSpine is offering 4.5 million shares of its common stock at a public offering price of $19.50 per share, leading to the $87.8 million expected in proceeds before deducting discounts, commissions and other expenses, according to a […]
